Passive Surveillance

Passive surveillance is a method of infectious disease monitoring in which data are collected through routine reporting by healthcare providers, laboratories, or other institutions to public health authorities.

This system depends on clinicians and labs recognizing cases of reportable diseases and submitting the required information without prompting or active follow-up from public health staff.

Passive surveillance is the backbone of most national and subnational disease monitoring systems because it is relatively low-cost, scalable, and capable of capturing long-term trends.

How passive surveillance works

It is used for a wide range of infectious diseases, including tuberculosis, syphilis, malaria, hepatitis, and foodborne illnesses like salmonellosis.

Core characteristics of passive surveillance

Standardized reporting protocols allow data aggregation across time and geography.

Diseases commonly monitored through passive surveillance

• Tuberculosis
• Chlamydia trachomatis
• Hepatitis A, B, and C
• Foodborne illnesses (e.g., Salmonella, Campylobacter)
• Syphilis and other STIs
• Vector-borne diseases like malaria or dengue

Healthcare settings that contribute to passive systems

• Primary care clinics
• Hospital inpatient and outpatient departments
• Urgent care and emergency departments
• Commercial and public health laboratories
• Sexual health and STI clinics

These sources report data based on standardized case definitions using clinical and lab criteria.

Examples of passive surveillance in action

• Chlamydia case reporting in the United States
• National TB reporting by clinicians and labs
• State-mandated notifiable disease registries

Public health uses of passive surveillance data

• Monitoring long-term trends
• Assessing geographic and demographic disparities
• Identifying baseline levels of disease

Case study: Chlamydia reporting in the U.S.

How the system functions

Chlamydia is a nationally notifiable disease, with automated lab and provider reporting to health departments.

• Data compiled at local, state, and national levels
• Used to guide prevention and screening programs
• Highlights burden among young women and underserved groups

Strengths of passive surveillance

Efficient and broad in scope, especially for diseases with routine testing.

• Cost-effective for long-term monitoring
• Useful for resource allocation and planning
• Builds comprehensive datasets over time

Limitations of passive systems

They may not capture all cases due to underdiagnosis or underreporting.

• Misses asymptomatic or mild cases
• Reporting delays can affect timely response
• Data quality varies by jurisdiction and system design

Why passive surveillance still matters

Despite its weaknesses, it remains essential for understanding disease patterns and trends.

Enhancing passive surveillance systems

• Improve electronic reporting infrastructure
• Train clinicians on reporting requirements
• Incentivize timely and complete case submission

Integrating passive with other approaches

• Combine with active surveillance for completeness
• Use sentinel sites to validate trends
• Incorporate lab-based and syndromic data for triangulation

Looking forward

Future improvements to passive surveillance

• Standardize electronic case definitions across systems
• Integrate laboratory and clinical data sources
• Automate real-time alerts and anomaly detection
• Address disparities in data capture and access
• Link to genomic and demographic information for richer insights